98 related articles for article (PubMed ID: 1403666)
1. [The mechanism of the renal excretion of disopyramide in rats. I].
Ito T; Takahashi Y; Tomidokoro K; Nishino T; Fukuzawa Y; Chiba K; Miyazaki S; Takada M
Yakugaku Zasshi; 1992 May; 112(5):336-42. PubMed ID: 1403666
[TBL] [Abstract][Full Text] [Related]
2. [The uptake of nalidixic acid and enoxacin by rat renal cortical slices in rat].
Oda M; Sasaya M; Hirano T; Nakajima Y; Iwata K; Chiba K; Miyazaki S; Takada M
Yakugaku Zasshi; 1995 May; 115(5):394-9. PubMed ID: 7595867
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of cimetidine by kidney cortex slices.
Cacini W; Keller MB; Grund VR
J Pharmacol Exp Ther; 1982 May; 221(2):342-6. PubMed ID: 7077528
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
Lin JH; Los LE; Ulm EH; Duggan DE
Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
[TBL] [Abstract][Full Text] [Related]
6. Elimination kinetics and urinary excretion of disopyramide in human healthy volunteers.
Bonde J; Jensen NM; Pedersen LE; Graudal NA; Angelo HR; Kampmann JP
Pharmacol Toxicol; 1988 May; 62(5):298-301. PubMed ID: 3413032
[TBL] [Abstract][Full Text] [Related]
7. Renal handling of alendronate in rats. An uncharacterized renal transport system.
Lin JH; Chen IW; Deluna FA; Hichens M
Drug Metab Dispos; 1992; 20(4):608-13. PubMed ID: 1356743
[TBL] [Abstract][Full Text] [Related]
8. Renal secretion of 3'-azido-3'-deoxythymidine by the rat.
Chatton JY; Odone M; Besseghir K; Roch-Ramel F
J Pharmacol Exp Ther; 1990 Oct; 255(1):140-5. PubMed ID: 2213549
[TBL] [Abstract][Full Text] [Related]
9. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
Muirhead MR; Somogyi AA
Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
[TBL] [Abstract][Full Text] [Related]
10. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
Aiba T; Sakurai Y; Tsukada S; Koizumi T
J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of renal tubular secretion and reabsorption of levofloxacin in rats.
Yano I; Ito T; Takano M; Inui K
Pharm Res; 1997 Apr; 14(4):508-11. PubMed ID: 9144740
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
13. Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats.
Yanxiao C; Ruijuan X; Jin Y; Lei C; Qian W; Xuefen Y; Hong T; Xueying Z; Davey AK; Jiping W
Life Sci; 2011 Jul; 89(1-2):1-6. PubMed ID: 21466809
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the renal effects and renal elimination of sulotroban in the dog.
Mann WA; Welzel GE; Goldstein RS; Sozio RS; Cyronak MJ; Kao J; Kinter LB
J Pharmacol Exp Ther; 1991 Dec; 259(3):1231-40. PubMed ID: 1762070
[TBL] [Abstract][Full Text] [Related]
15. The renal clearance of disopyramide after bolus intravenous injection.
Lawrence JR; Bryson SM; Sumner DJ; Campbell BC; Whiting B
Biopharm Drug Dispos; 1979; 1(2):51-7. PubMed ID: 552861
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
[TBL] [Abstract][Full Text] [Related]
17. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
Lin JH; Chen IW; Ulm EH; Duggan DE
Drug Metab Dispos; 1988; 16(3):392-6. PubMed ID: 2900730
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a secretory component in the handling of unconjugated bilirubin by the isolated perfused rat kidney.
Elías MM; Comin EJ; Ochoa EJ; Rodríguez Garay EA
Can J Physiol Pharmacol; 1985 Dec; 63(12):1581-5. PubMed ID: 3830355
[TBL] [Abstract][Full Text] [Related]
19. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Tamhane M; Chakilam AR; Jayaraj A; Thakkar V; Taft DR
Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
